Xeris Biopharma Holdings, Inc. (XERS) Operating Lease, Right-of-Use Asset USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2021 to 2024.
  • Xeris Biopharma Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $23 M, a 493% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $23 M +$19.1 M +493% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $23.2 M +$19.2 M +481% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 $23.4 M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $23.6 M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $3.89 M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.99 M +$3.99 M Dec 31, 2022 10-K 2024-03-06
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.